BUZZ-Hims & Hers Health shares fall after the company lowered its 2026 revenue forecast

November 9 - ** The health and wellness platform Hims & Hers Health (HIMS.N) saw its stock price fall 2.3% to close at $22.46 in after-hours trading

** The company lowered its annual revenue forecast (link) to a range below Wall Street expectations, as its expansion into branded weight-loss drugs and international markets led to a narrowing of its gross margin

** The company now expects 2026 revenue to be between $3.13 billion and $3.15 billion, compared to a previous forecast of $3.10 billion to $3.30 billion

** According to data compiled by London Stock Exchange Group (LSEG), analysts had expected $3.21 billion

** HIMS reported third-quarter revenue of $890.4 million, missing expectations of $892.9 million

** As of the close of the previous trading day, HIMS is down 29.3% year-to-date

(For the convenience of non-English speakers, Reuters has automated the translation of its reports into several other languages. As automated translation may contain errors or may not provide the required context, Reuters does not guarantee the accuracy of automated translations and provides them for readers’ convenience only. Reuters accepts no liability for any damage or loss caused by the use of automated translation features.)